KOREA PHARMA Co., Ltd. (032300.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩8,170 (+0.74%) as of
Key statistics
- Market cap
- 89.11B
- Dividend yield
- 0.62%
- 52-week range
- 6,350.00 – 14,950.00
- Beta
- 0.67
- Revenue (TTM)
- 93.94B
- Profit margin
- -0.82%
- Volume
- 13.31k
About KOREA PHARMA Co., Ltd.
KOREA PHARMA Co., Ltd. produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.